
1. Technology overview
Galatek is a Singapore-headquartered automation and AI company with its global head office and R&D centre in Singapore, offices in Munich and Massachusetts, R&D in Silicon Valley and Japan, and delivery and service teams across Southeast Asia. It addresses manual, fragmented workflows in drug discovery, diagnostics and biology labs, and also supplies inspection equipment to semiconductor makers.
For life sciences it supplies liquid handling workstations, integrated 2D and 3D cell culture, Perspecta high-content imaging, high-throughput drug discovery and chemical synthesis systems, smart plate handlers and collaborative AGV robots that move samples between instruments. Its Abio software combines an electronic lab notebook, LIMS and scientific data management with robot integration and cloud-agnostic operation, and the InteVega AI vision platform analyses cell images. Customers are pharmaceutical firms, biotech companies and research institutions.
2. Highlighted features & specifications
- Liquid handling workstations: automated pipetting for assays and sample preparation.
- 2D and 3D cell culture: integrated systems including organoid workflows.
- Perspecta imaging: high-content cell imaging analysed with the InteVega AI vision platform.
- Drug discovery automation: high-throughput screening and integrated chemical synthesis systems.
- Collaborative AGV robots: mobile robots that move samples and consumables between stations.
- Abio software: ELN, LIMS and scientific data management linked to lab robots.
3. Potential application
Vietnamese pharmaceutical R&D centres can automate screening and sample preparation with liquid handlers and plate handlers. Molecular diagnostics and genetic testing labs can raise throughput with automated workflows and LIMS. Universities and biotech institutes can set up smart labs for cell culture and organoid research.
4. Benefits
Connects records, instruments and robots so labs can run workflows with less manual handling. The company reports more than 34 million automated sample runs and 320 issued patents. One vendor covers hardware, software and service, with delivery teams in Southeast Asia and a manufacturing hub in Penang. Modular systems let labs automate one step first and scale to an integrated line.
5. Market trends & opportunities
Pharmaceutical and diagnostics labs face staff shortages and rising sample volumes, which pushes demand for automation and AI-ready lab data. Organoid and 3D cell models are replacing some animal testing in drug discovery. In Southeast Asia, Singapore and Malaysia are building biomanufacturing and research hubs, and Vietnam's growing testing and biotech sector will need scalable automation.
6. Other information
Headquartered at 21 Media Circle, Singapore, with 1,000+ employees stated on its site. Raised about US$30 million Series A in December 2025. Co-built smart labs with the National University of Singapore. Partnered with MissionDx (2026) and a:head bio (2025). Opened a Penang manufacturing hub in 2026.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE








































